Why the Future of Privacy Feels Like a Trap https://www.bulbapp.io/p/f059bdbc-f5e0-410c-a06a-a765c4475888/why-the-future-of-privacy-feels-like-atrap?s_id=6e58771d-ca7f-4685-9daf-ae0e7acd1cbd #privacy #AI

Voi Network isn’t here to serve the few, it’s built for the people🌍 Transparent, fast, scalable, and community-owned. Voi is a movement toward user-powered ecosystems where creators, builders, and everyday users have real control. It is about freedom, fairness, and future-ready infrastructure. Real utility. Real decentralization. Real people. 75% of the token supply goes to creators, builders, and node runners. If you want to support the Voi network and earn rewards, you can run a Func Voi participation node on your own machine. Func is a cross‑platform app that wraps all the Voi/Algorand node nerdiness in a simple interface, so you don’t have to touch the command line if you don’t want to. The basic flow looks like this: Download and install Func for your OS (Windows, Mac, or Linux), then choose Voi as the network. Let Func deploy and start the Voi node software in the background and fully sync to the network. This initial sync can take a few hours depending on your connection. Connect your Voi-compatible wallet, grab a small amount of VOI from the Fountain faucet so your account can participate, and fund the node address. Generate and register your participation keys inside the app, which is what actually lets your node help validate blocks and earn rewards. Leave Func running so your node stays online, check that it’s caught up and participating, and periodically refresh your participation keys when required. Once it’s set up, you’re basically turning your spare hardware and bandwidth into decentralization power for a people-first chain, and getting paid in VOI for doing it. Check out the Voi Website to learn more: https://voi.network/ #blockchain  #forthepeople  #algorand  #voiblockchain  #earncrypto 

The CLARITY Act: Crypto's Big Regulatory Hope or Investor Trap? https://www.bulbapp.io/p/678742d4-6477-4fe5-96fb-3ad4dcf34037/the-clarity-act-cryptos-big-regulatory-hope-or-investortrap #news #crypto #clarityact

I am a Meme Coin Millionaire 👀 https://audius.co/Hatty/meme-coin-millionaire #rap @audius #music #beats

People in nations with unstable economies are depending on stablecoins like Tether and USDC but they can't use Cardano to do it so they end up using Ethereum and Tron. I hope this changes one day. https://cointelegraph.com/news/tether-role-venezuela-iran-highlights-stablecoin-duality

One Node At a Time 🌍 https://audius.co/Hatty/one-node-at-a-time-🌍 #music #beats #rap #hiphop #violin

Your identity. Your control. 🔐 Veridian eliminates the middlemen in digital identity verification. No more depending on centralized platforms to prove who you are. How it works: ✅ KERI - Cryptographic proof you own your identity ✅ Verifiable Credentials - Share only what you need to share Built on open standards. Designed for privacy. Ready today. #cardanofoundation #cardano #bitcoin #changemakersnft #veridian

$GSAT Significant agreement from Globalstar! 🛡️ Government Contracts and Defense Technology Initiative - Globalstar has signed multiple government contracts expected to generate at least $60 million in revenue over the next five years. - These contracts cover the company's satellite-enabled software-defined communications solutions. - Thanks to the collaboration with Parsons, proof-of-concept for use in signal-disruption environments has been completed and commercialization has begun. 📡 Technological Developments - Globalstar's XCOM RAN technology is being evaluated for a high-capacity architecture in 5G defense applications. - The plug-and-play architecture, combined with Band 53 spectrum assets, enables rapid deployment for critical missions. - A collaborative R&D agreement has been signed with the US Army: Edge computing capabilities will be demonstrated for enhanced situational awareness in tactical environments. 🌍 Infrastructure and Global Expansion - The company has begun construction to expand its ground station in Singapore. The new antennas will support the third-generation C-3 mobile satellite system. This expansion will increase service capacity in Southeast Asia, building on a 17-year partnership with Singtel.

$HIMS Hims & Hers' Weight Loss Strategy Shakes Up Balance Sheet Metrics! 📉 Telehealth platform Hims & Hers surprised investors by missing Wall Street expectations for the first time, despite a 73% year-over-year increase in revenue to $544.8 million in the second quarter. This led to a 13% post-session drop in the stock. The primary reason behind this unexpected decline in figures is forced changes to the company's GLP-1 (weight loss) drug strategy. With the FDA's end of the semaglutide shortage, Hims was forced to change its sales model for more affordable generic GLP-1 drugs. This led to a decline in online GLP-1 revenue from $230 million in the first quarter to $190 million in the second quarter, and a decrease in average revenue per subscriber from $84 to $74. While the company achieved 31% year-over-year subscriber growth, reaching 2.4 million subscribers, uncertainties surrounding its GLP-1 strategy and developments such as the termination of its partnership with Novo Nordisk cast doubt on its growth narrative. Negative free cash flow is another concern. Hims & Hers will now attempt to navigate this challenging period by focusing on personalized GLP-1 therapies.

📊 $LLY | Eli Lilly Q2'25 Financial Results Strong Growth, Deepening Pipeline 🔹 Revenue: $15.56B (+38% YoY) 🟢 🔹 Adjusted EPS: $6.31 (+61% YoY) 🟢 🔹 Zepbound: $3.38B (+172%) 🔹 Mounjaro: $5.20B (+68%) 💡 Zepbound and Mounjaro solidify Eli Lilly's leadership in the metabolic diseases segment, with this quarter's results demonstrating momentum for both prescription penetration and patient acceptance of these products. 📌 FY25 guidance revised upward: ▫️ Revenue: $60–62B ▫️ Adj. EPS: $21.75–$23.00 🔬 Positive developments in the pipeline (Orforglipron, Jaypirca, Kisunla) present very strong catalysts that will support growth in the medium to long term. 💼 It also appears to be continuing its focus on innovation with the acquisitions of SiteOne and Verve Therapeutics and the Purdue collaboration. 📈 Comment: Eli Lilly is demonstrating not only strong sales growth but also a structural transformation. Supported by its leadership in the GLP-1 class, cardiometabolic protection data, and R&D investments, the pipeline offers a defensive and growth combination for long-term investors. #LLY #EliLilly #Balance Sheet #GLP1 #Zepbound #Mounjaro #HealthcareSector #StockAnalysis

Researchers at KAIST have made a revolutionary discovery! 🧬🔬 ​Using an artificial intelligence tool called BENEIN, they identified key genes (MYB, HDAC2, and FOXA2) that drive cancer cell behavior. By silencing just these three genes, they reprogrammed aggressive colorectal cancer cells to behave like normal intestinal tissue. In mice, tumors shrank by 70% without radiation, surgery, or chemotherapy. This approach could mark the beginning of a new era in cancer treatment, focusing on healing, not eradication. #Cancer #AI #ArtificialIntelligence #Medicine #Health #KAIST #BENEIN #Science #Genetics

https://cointelegraph.com/news/indonesia-exploring-bitcoin-reserve-strategy #cryptonews #indonesia #bitcoin #changemakersnft